169 related articles for article (PubMed ID: 67211)
21. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
Chauvenet PH; Smith RT
Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
[TBL] [Abstract][Full Text] [Related]
22. A highly sensitive and reproducible microcytotoxicity assay for demonstrating cytotoxic antibodies to cell surface antigens.
Hellström I; Brown JP; Klitzman JM; Hellström KE
J Immunol Methods; 1978; 22(3-4):369-81. PubMed ID: 681761
[TBL] [Abstract][Full Text] [Related]
23. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
[TBL] [Abstract][Full Text] [Related]
24. Antigenicity of carcinogen and viral induced sarcomas in inbred and random bred guinea pigs.
Forni G; Rhim JS; Pickeral S; Shevach EM; Green I
J Immunol; 1975 Jul; 115(1):204-10. PubMed ID: 50348
[TBL] [Abstract][Full Text] [Related]
25. Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogens.
Fritze D; Kern DH; Humme JA; Drogemuller CR; Pilch YH
Int J Cancer; 1976 Jan; 17(1):138-47. PubMed ID: 1248898
[TBL] [Abstract][Full Text] [Related]
26. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
Bubeník J; Indrová M; Malkovský M; Símová J
Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
[TBL] [Abstract][Full Text] [Related]
27. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
Livingston PO; DeLeo AB; Jones M; Oettgen HF
J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
[TBL] [Abstract][Full Text] [Related]
28. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
Dudley ME; Roopenian DC
J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy of murine sarcomas with auto-anti-idiotypic monoclonal antibodies which bind to tumor-specific T cells.
Nelson KA; George E; Swenson C; Forstrom JW; Hellström KE
J Immunol; 1987 Sep; 139(6):2110-7. PubMed ID: 2957449
[TBL] [Abstract][Full Text] [Related]
30. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.
Itoh T; Storkus WJ; Gorelik E; Lotze MT
J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of tumor outgrowth by tumor-associated blocking factors.
Hellström KE; Hellström I
Int J Cancer; 1979 Mar; 23(3):366-73. PubMed ID: 437919
[TBL] [Abstract][Full Text] [Related]
32. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
Konda S; Smith RT
Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
[No Abstract] [Full Text] [Related]
33. Immunity to MCA-induced rat sarcomas: analysis of in vivo and in vitro results.
Harmon RC; Clark EA; Reddy AL; Hildemann WH; Mullen Y
Int J Cancer; 1977 Nov; 20(5):748-58. PubMed ID: 924692
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
Hellström KE; Hellström I
Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
[TBL] [Abstract][Full Text] [Related]
35. Cytolytic antibodies to methylcholanthrene-induced sarcomas elicited by immunization of syngeneic mice.
Merino F; Abeyounis CJ; Milgrom F
Eur J Cancer (1965); 1979 Jun; 15(6):829-35. PubMed ID: 499271
[No Abstract] [Full Text] [Related]
36. The roles of two peritoneal T-lymphocyte populations in the in vivo rejection of methylcolanthrene-induced sarcoma.
Kadhim SA; Rees RC; Barrington-Leigh J
Cell Immunol; 1985 Jan; 90(1):234-41. PubMed ID: 2578328
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
Hellström I; Hellström KE
Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
[TBL] [Abstract][Full Text] [Related]
38. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
Shiku H; Bean MA; Old LJ; Oettgen HF
J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
[TBL] [Abstract][Full Text] [Related]
40. Antibody response of mice to chemically induced tumors.
Brown JP; Klitzman JM; Hellström I; Nowinski RC; Hellström KE
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):955-8. PubMed ID: 204940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
